ID   ACTNA_DICDI             Reviewed;         861 AA.
AC   P05095; Q55EP1;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   20-MAR-2007, sequence version 2.
DT   22-JUL-2015, entry version 132.
DE   RecName: Full=Alpha-actinin A;
DE   AltName: Full=Actin-binding protein A;
DE   AltName: Full=F-actin cross-linking protein;
GN   Name=abpA; Synonyms=actnA; ORFNames=DDB_G0268632;
OS   Dictyostelium discoideum (Slime mold).
OC   Eukaryota; Amoebozoa; Mycetozoa; Dictyosteliida; Dictyostelium.
OX   NCBI_TaxID=44689;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=AX2;
RX   PubMed=3622778; DOI=10.1016/0014-5793(87)80962-6;
RA   Noegel A., Witke W., Schleicher M.;
RT   "Calcium-sensitive non-muscle alpha-actinin contains EF-hand
RT   structures and highly conserved regions.";
RL   FEBS Lett. 221:391-396(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=15875012; DOI=10.1038/nature03481;
RA   Eichinger L., Pachebat J.A., Gloeckner G., Rajandream M.A.,
RA   Sucgang R., Berriman M., Song J., Olsen R., Szafranski K., Xu Q.,
RA   Tunggal B., Kummerfeld S., Madera M., Konfortov B.A., Rivero F.,
RA   Bankier A.T., Lehmann R., Hamlin N., Davies R., Gaudet P., Fey P.,
RA   Pilcher K., Chen G., Saunders D., Sodergren E.J., Davis P.,
RA   Kerhornou A., Nie X., Hall N., Anjard C., Hemphill L., Bason N.,
RA   Farbrother P., Desany B., Just E., Morio T., Rost R., Churcher C.M.,
RA   Cooper J., Haydock S., van Driessche N., Cronin A., Goodhead I.,
RA   Muzny D.M., Mourier T., Pain A., Lu M., Harper D., Lindsay R.,
RA   Hauser H., James K.D., Quiles M., Madan Babu M., Saito T.,
RA   Buchrieser C., Wardroper A., Felder M., Thangavelu M., Johnson D.,
RA   Knights A., Loulseged H., Mungall K.L., Oliver K., Price C.,
RA   Quail M.A., Urushihara H., Hernandez J., Rabbinowitsch E., Steffen D.,
RA   Sanders M., Ma J., Kohara Y., Sharp S., Simmonds M.N., Spiegler S.,
RA   Tivey A., Sugano S., White B., Walker D., Woodward J.R., Winckler T.,
RA   Tanaka Y., Shaulsky G., Schleicher M., Weinstock G.M., Rosenthal A.,
RA   Cox E.C., Chisholm R.L., Gibbs R.A., Loomis W.F., Platzer M.,
RA   Kay R.R., Williams J.G., Dear P.H., Noegel A.A., Barrell B.G.,
RA   Kuspa A.;
RT   "The genome of the social amoeba Dictyostelium discoideum.";
RL   Nature 435:43-57(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 91-504, PROTEIN SEQUENCE OF
RP   126-139; 275-285; 293-309; 313-328; 397-405 AND 481-487, AND
RP   DEVELOPMENTAL STAGE.
RC   STRAIN=AX2;
RX   PubMed=3745276; DOI=10.1083/jcb.103.3.969;
RA   Witke W., Schleicher M., Lottspeich F., Noegel A.;
RT   "Studies on the transcription, translation, and structure of alpha-
RT   actinin in Dictyostelium discoideum.";
RL   J. Cell Biol. 103:969-975(1986).
RN   [4]
RP   FUNCTION.
RX   PubMed=6746725; DOI=10.1083/jcb.99.1.119s;
RA   Condeelis J., Vahey M., Carboni J.M., DeMey J., Ogihara S.;
RT   "Properties of the 120,000- and 95,000-dalton actin-binding proteins
RT   from Dictyostelium discoideum and their possible functions in
RT   assembling the cytoplasmic matrix.";
RL   J. Cell Biol. 99:119-126(1984).
RN   [5]
RP   FUNCTION, SUBUNIT, AND DISRUPTION PHENOTYPE.
RX   PubMed=3956480;
RA   Wallraff E., Schleicher M., Modersitzki M., Rieger D., Isenberg G.,
RA   Gerisch G.;
RT   "Selection of Dictyostelium mutants defective in cytoskeletal
RT   proteins: use of an antibody that binds to the ends of alpha-actinin
RT   rods.";
RL   EMBO J. 5:61-67(1986).
RN   [6]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=1732064; DOI=10.1016/0092-8674(92)90205-Q;
RA   Witke W., Schleicher M., Noegel A.A.;
RT   "Redundancy in the microfilament system: abnormal development of
RT   Dictyostelium cells lacking two F-actin cross-linking proteins.";
RL   Cell 68:53-62(1992).
RN   [7]
RP   FUNCTION, AND MUTAGENESIS OF ASP-742; ASP-744; ASP-746; GLU-753;
RP   ASP-778; ASP-780; SER-786 AND GLU-789.
RX   PubMed=8486739; DOI=10.1083/jcb.121.3.599;
RA   Witke W., Hofmann A., Koeppel B., Schleicher M., Noegel A.A.;
RT   "The Ca(2+)-binding domains in non-muscle type alpha-actinin:
RT   biochemical and genetic analysis.";
RL   J. Cell Biol. 121:599-606(1993).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=7820857; DOI=10.1002/cm.970290105;
RA   Furukawa R., Fechheimer M.;
RT   "Differential localization of alpha-actinin and the 30 kD actin-
RT   bundling protein in the cleavage furrow, phagocytic cup, and
RT   contractile vacuole of Dictyostelium discoideum.";
RL   Cell Motil. Cytoskeleton 29:46-56(1994).
RN   [9]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=8937986;
RA   Rivero F., Koeppel B., Peracino B., Bozzaro S., Siegert F.,
RA   Weijer C.J., Schleicher M., Albrecht R., Noegel A.A.;
RT   "The role of the cortical cytoskeleton: F-actin crosslinking proteins
RT   protect against osmotic stress, ensure cell size, cell shape and
RT   motility, and contribute to phagocytosis and development.";
RL   J. Cell Sci. 109:2679-2691(1996).
RN   [10]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=10411959;
RA   Weber I.;
RT   "Computer-assisted morphometry of cell-substratum contacts.";
RL   Croat. Med. J. 40:334-339(1999).
RN   [11]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=10413681;
RA   Rivero F., Furukawa R., Fechheimer M., Noegel A.A.;
RT   "Three actin cross-linking proteins, the 34 kDa actin-bundling
RT   protein, alpha-actinin and gelation factor (ABP-120), have both unique
RT   and redundant roles in the growth and development of Dictyostelium.";
RL   J. Cell Sci. 112:2737-2751(1999).
RN   [12]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=10704840; DOI=10.1016/S0925-4773(99)00292-0;
RA   Ponte E., Rivero F., Fechheimer M., Noegel A., Bozzaro S.;
RT   "Severe developmental defects in Dictyostelium null mutants for actin-
RT   binding proteins.";
RL   Mech. Dev. 91:153-161(2000).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 265-502.
RX   PubMed=11226153; DOI=10.1093/emboj/20.1.40;
RA   Kliche W., Fujita-Becker S., Kollmar M., Manstein D.J., Kull F.J.;
RT   "Structure of a genetically engineered molecular motor.";
RL   EMBO J. 20:40-46(2001).
CC   -!- FUNCTION: F-actin cross-linking protein which is thought to anchor
CC       actin to a variety of intracellular structures. This is a bundling
CC       protein. Increases the actin-stimulated ATPase activity of myosin.
CC       Involved in vegetative cell growth, phagocytosis, motility and
CC       development, probably through stabilization of the actin network
CC       in the cortical cytoskeleton. {ECO:0000269|PubMed:10411959,
CC       ECO:0000269|PubMed:10413681, ECO:0000269|PubMed:10704840,
CC       ECO:0000269|PubMed:1732064, ECO:0000269|PubMed:3956480,
CC       ECO:0000269|PubMed:6746725, ECO:0000269|PubMed:8486739,
CC       ECO:0000269|PubMed:8937986}.
CC   -!- SUBUNIT: Homodimer; antiparallel. {ECO:0000269|PubMed:3956480}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:7820857}.
CC       Cytoplasm, cell cortex {ECO:0000269|PubMed:7820857}. Contractile
CC       vacuole {ECO:0000269|PubMed:7820857}. Cytoplasmic vesicle,
CC       phagosome {ECO:0000269|PubMed:7820857}. Note=Expressed diffusely
CC       throughout the cytoplasm. Accumulates in the cell cortex,
CC       contractile vesicle and phagosome.
CC   -!- DEVELOPMENTAL STAGE: Expressed throughout development. Levels
CC       increase during aggregation (1-6 hours) and are then maintained
CC       until late culmination when they start to decrease.
CC       {ECO:0000269|PubMed:3745276}.
CC   -!- DISRUPTION PHENOTYPE: Cells show a minor impairment of growth
CC       under conditions of reduced temperature and hyperosmotic stress.
CC       Fruiting body development and spore production on soil plates is
CC       strongly impaired in mutants lacking abpA, but is only mildly
CC       affected in mutants on agar plates. Double mutants lacking both
CC       abpA and abpC show a marked reduction in growth, cell size and
CC       resistance to osmotic shock, and decreased motility and
CC       phagocytosis rates. Development is blocked at the tip stage of
CC       aggregation, although expression of developmentally regulated
CC       genes does not appear to be affected. Double mutants lacking abpA
CC       and abpB show a significant reduction in growth and a slight
CC       reduction in motility. Development appears to proceed normally
CC       until culmination when aberrant fruiting bodies are formed. The
CC       phenotypes of the double mutants suggests a partial redundancy in
CC       the microfilament system. {ECO:0000269|PubMed:10411959,
CC       ECO:0000269|PubMed:10413681, ECO:0000269|PubMed:10704840,
CC       ECO:0000269|PubMed:1732064, ECO:0000269|PubMed:3956480,
CC       ECO:0000269|PubMed:8937986}.
CC   -!- SIMILARITY: Belongs to the alpha-actinin family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 actin-binding domain. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 2 CH (calponin-homology) domains.
CC       {ECO:0000255|PROSITE-ProRule:PRU00044}.
CC   -!- SIMILARITY: Contains 2 EF-hand domains. {ECO:0000255|PROSITE-
CC       ProRule:PRU00448}.
CC   -!- SIMILARITY: Contains 4 spectrin repeats. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y00689; CAA68685.1; -; mRNA.
DR   EMBL; AAFI02000004; EAL72905.1; -; Genomic_DNA.
DR   EMBL; X04324; CAA27855.1; -; Genomic_DNA.
DR   PIR; S00103; FADOAA.
DR   RefSeq; XP_646979.1; XM_641887.1.
DR   PDB; 1G8X; X-ray; 2.80 A; A/B=265-502.
DR   PDB; 2YCU; X-ray; 2.25 A; A=263-502.
DR   PDB; 4PD3; X-ray; 2.84 A; A/B=265-502.
DR   PDBsum; 1G8X; -.
DR   PDBsum; 2YCU; -.
DR   PDBsum; 4PD3; -.
DR   ProteinModelPortal; P05095; -.
DR   SMR; P05095; 19-244, 265-502.
DR   STRING; 44689.DDB0191133; -.
DR   PRIDE; P05095; -.
DR   EnsemblProtists; DDB0191133; DDB0191133; DDB_G0268632.
DR   GeneID; 8616670; -.
DR   KEGG; ddi:DDB_G0268632; -.
DR   dictyBase; DDB_G0268632; abpA.
DR   eggNOG; COG5069; -.
DR   InParanoid; P05095; -.
DR   KO; K05699; -.
DR   OMA; EWAHGKE; -.
DR   PhylomeDB; P05095; -.
DR   Reactome; REACT_341046; Platelet degranulation.
DR   EvolutionaryTrace; P05095; -.
DR   PRO; PR:P05095; -.
DR   Proteomes; UP000002195; Chromosome 1.
DR   Proteomes; UP000002195; Unassembled WGS sequence.
DR   GO; GO:0005884; C:actin filament; IDA:dictyBase.
DR   GO; GO:0005938; C:cell cortex; IEA:UniProtKB-SubCell.
DR   GO; GO:0031252; C:cell leading edge; IDA:dictyBase.
DR   GO; GO:0000331; C:contractile vacuole; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:dictyBase.
DR   GO; GO:0045335; C:phagocytic vesicle; IEA:UniProtKB-SubCell.
DR   GO; GO:0051015; F:actin filament binding; IDA:dictyBase.
DR   GO; GO:0005509; F:calcium ion binding; IDA:dictyBase.
DR   GO; GO:0030674; F:protein binding, bridging; IDA:dictyBase.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; IDA:dictyBase.
DR   GO; GO:0051764; P:actin crosslink formation; IDA:UniProtKB.
DR   GO; GO:0051017; P:actin filament bundle assembly; IDA:dictyBase.
DR   GO; GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.238.10; -; 2.
DR   Gene3D; 1.10.418.10; -; 2.
DR   InterPro; IPR001589; Actinin_actin-bd_CS.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR014837; EF-hand_Ca_insen.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR018159; Spectrin/alpha-actinin.
DR   InterPro; IPR002017; Spectrin_repeat.
DR   Pfam; PF00307; CH; 2.
DR   Pfam; PF00036; EF-hand_1; 1.
DR   Pfam; PF13405; EF-hand_6; 1.
DR   Pfam; PF08726; EFhand_Ca_insen; 1.
DR   Pfam; PF00435; Spectrin; 3.
DR   SMART; SM00033; CH; 2.
DR   SMART; SM00054; EFh; 2.
DR   SMART; SM00150; SPEC; 4.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   PROSITE; PS00019; ACTININ_1; 1.
DR   PROSITE; PS00020; ACTININ_2; 1.
DR   PROSITE; PS50021; CH; 2.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Actin-binding; Calcium; Complete proteome; Cytoplasm;
KW   Cytoplasmic vesicle; Developmental protein; Direct protein sequencing;
KW   Metal-binding; Reference proteome; Repeat; Vacuole.
FT   CHAIN         1    861       Alpha-actinin A.
FT                                /FTId=PRO_0000073445.
FT   DOMAIN        1    239       Actin-binding.
FT   DOMAIN       22    127       CH 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00044}.
FT   DOMAIN      136    239       CH 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00044}.
FT   REPEAT      240    365       Spectrin 1.
FT   REPEAT      366    480       Spectrin 2.
FT   REPEAT      481    601       Spectrin 3.
FT   REPEAT      602    714       Spectrin 4.
FT   DOMAIN      729    764       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      765    800       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     742    753       1.
FT   CA_BIND     778    789       2.
FT   MUTAGEN     742    742       D->A: Abolishes cross-linking activity
FT                                and reduces calcium binding by 55%; when
FT                                associated with A-744; A-746 and A-753.
FT                                {ECO:0000269|PubMed:8486739}.
FT   MUTAGEN     744    744       D->A: Abolishes cross-linking activity
FT                                and reduces calcium binding by 55%; when
FT                                associated with A-742; A-746 and A-753.
FT                                {ECO:0000269|PubMed:8486739}.
FT   MUTAGEN     746    746       D->A: Abolishes cross-linking activity
FT                                and reduces calcium binding by 55%; when
FT                                associated with A-742; A-744 and A-753.
FT                                {ECO:0000269|PubMed:8486739}.
FT   MUTAGEN     753    753       E->A: Abolishes cross-linking activity
FT                                and reduces calcium binding by 55%; when
FT                                associated with A-742; A-744 and A-746.
FT                                {ECO:0000269|PubMed:8486739}.
FT   MUTAGEN     778    778       D->A: Decreases sensitivity to inhibition
FT                                by calcium; when associated with A-780;
FT                                A-786 and A-789.
FT                                {ECO:0000269|PubMed:8486739}.
FT   MUTAGEN     780    780       D->A: Decreases sensitivity to inhibition
FT                                by calcium; when associated with A-778;
FT                                A-786 and A-789.
FT                                {ECO:0000269|PubMed:8486739}.
FT   MUTAGEN     786    786       S->A: Decreases sensitivity to inhibition
FT                                by calcium; when associated with A-778;
FT                                A-780 and A-789.
FT                                {ECO:0000269|PubMed:8486739}.
FT   MUTAGEN     789    789       E->A: Decreases sensitivity to inhibition
FT                                by calcium; when associated with A-778;
FT                                A-780 and A-786.
FT                                {ECO:0000269|PubMed:8486739}.
FT   CONFLICT     78     78       R -> RR (in Ref. 1; CAA68685).
FT                                {ECO:0000305}.
FT   CONFLICT    359    359       T -> P (in Ref. 3; CAA27855).
FT                                {ECO:0000305}.
FT   CONFLICT    500    500       I -> T (in Ref. 3; CAA27855).
FT                                {ECO:0000305}.
FT   CONFLICT    675    675       A -> R (in Ref. 1; CAA68685).
FT                                {ECO:0000305}.
FT   CONFLICT    696    696       I -> L (in Ref. 1; CAA68685).
FT                                {ECO:0000305}.
FT   HELIX       263    281       {ECO:0000244|PDB:2YCU}.
FT   TURN        282    286       {ECO:0000244|PDB:2YCU}.
FT   HELIX       292    308       {ECO:0000244|PDB:2YCU}.
FT   HELIX       311    314       {ECO:0000244|PDB:2YCU}.
FT   HELIX       316    326       {ECO:0000244|PDB:2YCU}.
FT   STRAND      328    330       {ECO:0000244|PDB:2YCU}.
FT   TURN        339    341       {ECO:0000244|PDB:1G8X}.
FT   HELIX       342    386       {ECO:0000244|PDB:2YCU}.
FT   TURN        387    389       {ECO:0000244|PDB:2YCU}.
FT   HELIX       390    393       {ECO:0000244|PDB:2YCU}.
FT   HELIX       401    412       {ECO:0000244|PDB:2YCU}.
FT   HELIX       414    437       {ECO:0000244|PDB:2YCU}.
FT   TURN        438    440       {ECO:0000244|PDB:2YCU}.
FT   HELIX       446    453       {ECO:0000244|PDB:2YCU}.
FT   TURN        454    456       {ECO:0000244|PDB:2YCU}.
FT   HELIX       457    468       {ECO:0000244|PDB:2YCU}.
FT   HELIX       470    480       {ECO:0000244|PDB:2YCU}.
FT   STRAND      481    483       {ECO:0000244|PDB:2YCU}.
FT   HELIX       484    487       {ECO:0000244|PDB:1G8X}.
FT   TURN        489    494       {ECO:0000244|PDB:1G8X}.
FT   TURN        496    501       {ECO:0000244|PDB:1G8X}.
SQ   SEQUENCE   861 AA;  97358 MW;  17F4364B8059EAFA CRC64;
     MSEEPTPVSG NDKQLLNKAW EITQKKTFTA WCNSHLRKLG SSIEQIDTDF TDGIKLAQLL
     EVISNDPVFK VNKTPKLRIH NIQNVGLCLK HIESHGVKLV GIGAEELVDK NLKMTLGMIW
     TIILRFAIQD ISIEELSAKE ALLLWCQRKT EGYDRVKVGN FHTSFQDGLA FCALIHKHRP
     DLINFDSLNK DDKAGNLQLA FDIAEKELDI PKMLDVSDML DVVRPDERSV MTYVAQYYHH
     FSASRKAETA GKQVGKVLDT FMLLEQTKSD YLKRANELVQ WINDKQASLE SRDFGDSIES
     VQSFMNAHKE YKKTEKPPKG QEVSELEAIY NSLQTKLRLI KREPFVAPAG LTPNEIDSTW
     SALEKAEQEH AEALRIELKR QKKIAVLLQK YNRILKKLEN WATTKSVYLG SNETGDSITA
     VQAKLKNLEA FDGECQSLEG QSNSDLLSIL AQLTELNYNG VPELTERKDT FFAQQWTGVK
     SSAETYKNTL LAELERLQKI EDSLVEFAKR AAQLNVWIEA ADDHVFDPIN VDSVQGVQEI
     QEKFDAFLHD QSQQFAELEA LAALTQQLRE LGRSENDYSV ISYDELSAKW NNLLAGIEER
     KVQLANELTT QTNNDVLCQS FSVKANEISD YVRVTLDAIS QNTSSDPQEQ LNNIRAIITA
     HAEKKPELDE LYTIASQLEE AQVVDNKHTQ HSLESIKLKW DKLNTLAKKN EQVVEGEILA
     KQLTGVTAEE LSEFKACFSH FDKDNDNKLN RLEFSSCLKS IGDELTEEQL NQVISKIDTD
     GNGTISFEEF IDYMVSSRKG TDSVESTKAA FKVMAEDKDF ITEAQIRAAI SDSKQIDYLL
     ASMPAVEGGF DYNSFAEKLY Q
//
